08:30 - 10:00 Session 5: Quantification And Management Of The Bleeding Risk
Chair: A Falanga (Italy)
- Bleeding risk in coagulation factor deficiencies
G Castaman (Italy)
- Bleeding risk in thrombocytopenic patients
F Rodehiero (Italy)
- New insights in acquired bleeding disorders
J Paramo (Spain)
10:00 - 11:00 Session 6: Oral session 2
Chair: F Rodeghiero (Italy)
11:00 - 11:30 Coffee break
11:30 - 13:00 Session 7: Interactive session -Bleeding Risk Of Anti-coagulation
Chair: H ten Cate (The Netherlands)
- Anticoagulated subjects: Reversal strategies in emergency
P Verhamme (Belgium)
- Management of oral anticogulant therapy in elective surgery
J Arcelus (Spain)
- Risk/benefit of anticoagulant-antiplatelet therapy association
A ten Cate (The Netherlands)
13:00 - 14:30 Lunch break
13:30 - 14:30 Satellite Symposium Medscape: Moving Ahead in Chronic Immune Thrombocytopenia: How Can Recent Advances Help Our Patients?
Chair: N Cooper (United Kingdom)
- Chronic ITP: What Is It and How Is It Diagnosed?
N Cooper (United Kingdom)
- First- and Second Line Therapy for ITP: What Is the Latest?
F Zaja (Italy)
- Future Perspectives on the Management of Chronic ITP
J Bussel (USA)
- Panel Discussion, Q&A and Closing Remarks
N Cooper (United Kingdom)
14:30 - 16:00 Session 8: Thrombosis in Hematological Disorders
Chair: H Liebman (USA)
- Acute leukemias
H Liebman (USA)
- Myeloproliferative neoplasms
F Leebeek (The Netherlands)
- Paroxysmal nocturnal hemoglobinuria
B Devalet (Belgium)
16:00 - 16:30 Coffee break
16:30 - 17:30 Session 9: Round table
Chair: G Castaman (Italy)
Panelists:
- VJ Yuste (Spain)
- A García (Spain)
Back